We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
203.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.35%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$216M
AUM Growth
+$17.6M
(+8.9%)
Cap. Flow
-$4.87M
Cap. Flow
% of AUM
-2.25%
Top 10 Holdings %
Top 10 Hldgs %
44.96%
Holding
70
New
3
Increased
13
Reduced
28
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MODN
MODEL N, INC.
MODN
|
+$4.66M |
| 2 |
AKRX
Akorn Inc
AKRX
|
+$4.64M |
| 3 |
Option Care Health
OPCH
|
+$4.57M |
| 4 |
KTWO
K2M Group Holdings, Inc
KTWO
|
+$3.98M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$2.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$8.53M |
| 2 |
AngioDynamics
ANGO
|
+$3.36M |
| 3 |
ELGX
Endologix Inc
ELGX
|
+$3.12M |
| 4 |
Arrowhead Research
ARWR
|
+$2.37M |
| 5 |
Insmed
INSM
|
+$2.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.91% |
| 2 | Energy | 4.55% |
| 3 | Miscellaneous | 3.27% |
| 4 | Communication Services | 2.46% |
| 5 | Real Estate | 1.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Steris
STE
$20.5B
| $435K | 0.2% |
6,330
| – | – |
|
52
Eli Lilly
LLY
$1.01T
| $433K | 0.2% |
5,495
| – | – |
|
53
IRIDEX
IRIX
$11.1M
| $429K | 0.2% |
29,009
+2,000
| +7% | +$24.9K |
|
54
Viatris
VTRS
$19.1B
| $423K | 0.2% |
9,775
| – | – |
|
|
CELG
55
DELISTED
Celgene Corp
CELG
| $422K | 0.2% |
4,280
| – | – |
|
56
United Therapeutics
UTHR
$21.5B
| $405K | 0.19% |
3,820
| – | – |
|
57
Merck
MRK
$355B
| $381K | 0.18% |
6,927
| – | – |
|
58
Pfizer
PFE
$157B
| $370K | 0.17% |
11,088
| – | – |
|
59
Amgen
AMGN
$203B
| $355K | 0.16% |
2,330
| – | – |
|
60
AstraZeneca
AZN
$251B
| $343K | 0.16% |
5,680
| – | – |
|
|
STJ
61
DELISTED
St Jude Medical
STJ
| $305K | 0.14% |
3,911
-2,144
| -35% | -$153K |
|
62
Bio-Rad Laboratories Class A
BIO
$10.1B
| $240K | 0.11% |
1,675
| – | – |
|
63
Myriad Genetics
MYGN
$371M
| $239K | 0.11% |
7,820
| – | – |
|
64
Sanofi
SNY
$102B
| $238K | 0.11% |
5,680
| – | – |
|
65
Agilent Technologies
A
$42.4B
| $227K | 0.11% |
5,120
| – | – |
|
|
66
AngioDynamics
ANGO
$648M
| – | – |
-273,122
| Closed | -$3.36M |
|
|
67
Arrowhead Research
ARWR
$9.98B
| – | – |
-491,574
| Closed | -$2.37M |
|
68
Celldex Therapeutics
CLDX
$3.02B
| – | – |
-14,054
| Closed | -$797K |
|
|
69
Insmed
INSM
$26.2B
| – | – |
-177,930
| Closed | -$2.25M |
|
|
ENDP
70
DELISTED
Endo International plc
ENDP
| – | – |
-8,161
| Closed | -$230K |
|
Similar funds
AAM
NPA
SOS
BCM
BFO
AAG
MCIL
TIM
First Light Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, First Light Asset Management held 70 positions worth $216M, up 8.9% from $198M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
First Light Asset Management's Q2 2016 filing shows 3 new, 13 increased, 28 reduced and 5 closed positions. Its largest new stake was MODEL N, INC.: 397,152 shares worth $5.3M. The largest sale was NeoGenomics, an estimated $8.53M.
By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 92% a quarter earlier, followed by Energy and Miscellaneous.
- First Light Asset Management's largest Q2 2016 buy was MODEL N, INC.: 397,152 shares worth $5.3M.
- First Light Asset Management added most to Akorn Inc in Q2 2016, an estimated $4.64M increase.
- First Light Asset Management's biggest Q2 2016 reduction was NeoGenomics, cutting an estimated $8.53M.
- First Light Asset Management fully exited AngioDynamics in Q2 2016, selling an estimated $3.36M.
- First Light Asset Management's ten largest holdings make up 45% of its $216M portfolio in Q2 2016.
- First Light Asset Management opened 3 new positions and closed 5 in Q2 2016.
- First Light Asset Management's portfolio value rose 8.9% quarter-over-quarter to $216M.
Based on First Light Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.